IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide and a leading cause of chronic kidney disease and kidney failure. Despite recent advances in understanding its complex pathogenesis and emerging targeted therapies, significant gaps persist in healthcare professionals knowledge of IgAN and their appreciation of the profound effects this chronic disease has on patient quality of life. At the same time, the emerging IgAN treatment landscape has exploded, posing immediate knowledge gaps for clinicians as data from clinical trials on novel therapies becomes available. Moreover, the newly published KDIGO 2025 clinical practice guideline for the management of IgAN incorporates shifting treatment paradigms and new recommendations based on recent evidence from randomized controlled trials. These recommendations underscore the importance of early and accurate diagnosis, goal-setting in the management of proteinuria and disease progression, and use of recently approved therapies. A focused CME program is needed to equip healthcare providers with the latest evidence-based recommendations and emerging treatments to optimize patient well-being and outcomes and address the evolving therapeutic landscape for this progressive kidney disease.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 384 Inverness Parkway
Pricing
All courses included · from $18.75/mo
Courses are included in the subscription; some are also sold individually.
| Student Flex | $18.75/mo |
| Professional Flex | $60/mo |
| Student 3-Year | $100 |
| Student 2-Year | $112.50 |
+4 more plans
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Maternal-Fetal Medicine
- Medical Leadership & Administration
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Plastic & Reconstructive Surgery
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Surgical Oncology
- Thoracic Anesthesia
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Conference / congress
- includes Board review / self-assessment
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 10, 2025
-
Last day to claim creditNov 1, 2026 3 weeks left
-
CMEology +1 New KDIGO IgAN Clinical Practice Guidelines: Improving Patient Lives and Outcomes
-
CMEology +1 Advancing IgA Nephropathy Care: Case-Based Perspectives and Key Insights From the ERA Congress
-
Plexus Communications +1 Navigating the Complexities of Treating Acute and Chronic Graft-vs-Host Disease With Targeted Agents
